Home > Drug Search >
  • company_query: Alfresa Pharma
  •   > 
Drug Filter
Category:
chemistry (15) biology (5)
Status:
Approved (5) Phase Ⅲ (1) Phase Ⅱ (6) Phase Ⅰ (7) IND Filing (1)
Clinical Stage:
Pending (2) Active (5) Discontinued (7)
Bio-Type:
Recombinant polypeptide (1) Recombinant glycoprotein (1) Whole antibody (2)
Indication:
Alzheimer's disease (AD) (1) Angina pectoris (1) Breast cancer (1) Cognitive disorders (1) Giardia lamblia disease (1) Cryptococcus neoformans (1) Gastric cancer (2) Gastrointestinal stromal tumors (GISTs) (2) Heart failure (1) Huntington's disease (1) Insomnia (1) Lung cancer (2) Non small cell lung cancer (NSCLC) (1) Parkinson's disease (PD) (2) Prostate cancer (1) Rheumatoid arthritis (RA) (1) Solid tumours (2) Ulcerative colitis (1) Metastatic non-small cell lung cancer (1) Gastroesophageal junction adenocarcinoma (1) Renal carcinoma (1) Diarrhea caused by giardia or cryptosporidium (1) Hereditary angioedema (HAE) (3) Pruritus (1) Ischemic stroke (1) Thrombosis (1) Drug-induced dyskinesia (1) Liver cancer (1) Cardiovascular disorders (1) Opioid abuse (1)
Aprv. Year:
2002 (1) 2008 (1) 2014 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top